vs

Side-by-side financial comparison of EAGLE FINANCIAL SERVICES INC (EFSI) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

AVITA Medical, Inc. is the larger business by last-quarter revenue ($17.6M vs $16.4M, roughly 1.1× EAGLE FINANCIAL SERVICES INC). On growth, EAGLE FINANCIAL SERVICES INC posted the faster year-over-year revenue change (21.3% vs -4.3%). EAGLE FINANCIAL SERVICES INC produced more free cash flow last quarter ($24.3M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 1.5%).

Ally Financial Inc. is an American bank holding company incorporated in Delaware and headquartered at Ally Detroit Center in Detroit, Michigan. The company provides financial services including car finance, online banking via a direct bank, corporate lending, vehicle insurance, mortgage loans, and other related financing services such as installment sale and lease agreements.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

EFSI vs RCEL — Head-to-Head

Bigger by revenue
RCEL
RCEL
1.1× larger
RCEL
$17.6M
$16.4M
EFSI
Growing faster (revenue YoY)
EFSI
EFSI
+25.6% gap
EFSI
21.3%
-4.3%
RCEL
More free cash flow
EFSI
EFSI
$30.5M more FCF
EFSI
$24.3M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
1.5%
EFSI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EFSI
EFSI
RCEL
RCEL
Revenue
$16.4M
$17.6M
Net Profit
$-11.6M
Gross Margin
81.2%
Operating Margin
33.6%
-59.1%
Net Margin
-66.0%
Revenue YoY
21.3%
-4.3%
Net Profit YoY
-0.3%
EPS (diluted)
$1.10
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EFSI
EFSI
RCEL
RCEL
Q4 25
$16.4M
$17.6M
Q3 25
$22.4M
$17.1M
Q2 25
$20.6M
$18.4M
Q1 25
$4.8M
$18.5M
Q4 24
$22.0M
$18.4M
Q3 24
$18.4M
$19.5M
Q2 24
$16.5M
$15.2M
Q1 24
$15.9M
$11.1M
Net Profit
EFSI
EFSI
RCEL
RCEL
Q4 25
$-11.6M
Q3 25
$5.6M
$-13.2M
Q2 25
$5.3M
$-9.9M
Q1 25
$-7.0M
$-13.9M
Q4 24
$-11.6M
Q3 24
$3.4M
$-16.2M
Q2 24
$3.2M
$-15.4M
Q1 24
$2.5M
$-18.7M
Gross Margin
EFSI
EFSI
RCEL
RCEL
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
EFSI
EFSI
RCEL
RCEL
Q4 25
33.6%
-59.1%
Q3 25
30.9%
-53.6%
Q2 25
31.8%
-60.5%
Q1 25
-189.0%
-63.9%
Q4 24
36.8%
-54.1%
Q3 24
21.6%
-70.6%
Q2 24
22.9%
-102.8%
Q1 24
19.1%
-155.0%
Net Margin
EFSI
EFSI
RCEL
RCEL
Q4 25
-66.0%
Q3 25
25.0%
-77.3%
Q2 25
25.6%
-53.9%
Q1 25
-145.8%
-74.9%
Q4 24
-63.0%
Q3 24
18.6%
-82.9%
Q2 24
19.3%
-101.3%
Q1 24
16.0%
-168.0%
EPS (diluted)
EFSI
EFSI
RCEL
RCEL
Q4 25
$1.10
$-0.37
Q3 25
$1.04
$-0.46
Q2 25
$0.98
$-0.38
Q1 25
$-1.53
$-0.53
Q4 24
$1.74
$-0.44
Q3 24
$0.97
$-0.62
Q2 24
$0.89
$-0.60
Q1 24
$0.72
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EFSI
EFSI
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$188.8M
$-16.6M
Total Assets
$1.9B
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EFSI
EFSI
RCEL
RCEL
Q4 25
$18.2M
Q3 25
$23.3M
Q2 25
$15.7M
Q1 25
$25.8M
Q4 24
$35.9M
Q3 24
$44.4M
Q2 24
$54.1M
Q1 24
$68.2M
Stockholders' Equity
EFSI
EFSI
RCEL
RCEL
Q4 25
$188.8M
$-16.6M
Q3 25
$185.6M
$-6.7M
Q2 25
$179.6M
$-12.9M
Q1 25
$176.5M
$-4.6M
Q4 24
$119.0M
$4.5M
Q3 24
$117.8M
$12.2M
Q2 24
$111.1M
$23.9M
Q1 24
$107.7M
$32.6M
Total Assets
EFSI
EFSI
RCEL
RCEL
Q4 25
$1.9B
$56.4M
Q3 25
$1.9B
$63.7M
Q2 25
$2.0B
$58.1M
Q1 25
$1.9B
$69.6M
Q4 24
$1.9B
$79.7M
Q3 24
$1.9B
$81.1M
Q2 24
$1.8B
$87.8M
Q1 24
$1.8B
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EFSI
EFSI
RCEL
RCEL
Operating Cash FlowLast quarter
$25.8M
$-5.4M
Free Cash FlowOCF − Capex
$24.3M
$-6.1M
FCF MarginFCF / Revenue
148.6%
-34.7%
Capex IntensityCapex / Revenue
8.6%
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$39.7M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EFSI
EFSI
RCEL
RCEL
Q4 25
$25.8M
$-5.4M
Q3 25
$8.2M
$-5.2M
Q2 25
$2.6M
$-10.2M
Q1 25
$5.8M
$-10.3M
Q4 24
$18.8M
$-8.1M
Q3 24
$7.5M
$-7.2M
Q2 24
$-1.8M
$-12.8M
Q1 24
$6.8M
$-20.9M
Free Cash Flow
EFSI
EFSI
RCEL
RCEL
Q4 25
$24.3M
$-6.1M
Q3 25
$7.8M
$-6.2M
Q2 25
$2.3M
$-10.8M
Q1 25
$5.3M
$-10.5M
Q4 24
$17.7M
$-9.7M
Q3 24
$7.3M
$-11.0M
Q2 24
$-2.2M
$-15.4M
Q1 24
$6.7M
$-22.0M
FCF Margin
EFSI
EFSI
RCEL
RCEL
Q4 25
148.6%
-34.7%
Q3 25
35.0%
-36.1%
Q2 25
11.2%
-58.4%
Q1 25
110.1%
-56.9%
Q4 24
80.6%
-52.7%
Q3 24
39.6%
-56.1%
Q2 24
-13.6%
-101.6%
Q1 24
41.9%
-198.2%
Capex Intensity
EFSI
EFSI
RCEL
RCEL
Q4 25
8.6%
3.8%
Q3 25
1.7%
5.5%
Q2 25
1.3%
2.8%
Q1 25
11.2%
1.2%
Q4 24
4.6%
8.8%
Q3 24
1.3%
19.2%
Q2 24
2.6%
17.5%
Q1 24
0.6%
10.3%
Cash Conversion
EFSI
EFSI
RCEL
RCEL
Q4 25
Q3 25
1.47×
Q2 25
0.49×
Q1 25
Q4 24
Q3 24
2.19×
Q2 24
-0.57×
Q1 24
2.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EFSI
EFSI

Asset Management$6.0M37%
Other$3.8M23%
Interchange Fees$3.5M22%
Overdrawn Account Fees$1.6M10%
Brokerage Commissions$1.4M9%

RCEL
RCEL

Segment breakdown not available.

Related Comparisons